The New Shape of Longevity GLP-1 medications are changing the way doctors think about weight loss, metabolism, and aging
placebo in patients who were overweight or obese and showed sustained, clinically relevant weight loss and improvement in lipid parameters
Tasnim Rahman, 31 My skin got visibly brighter in just 1 month and dark spots are fading
Service & Compliance Process This is a Procurement Facilitation Service
Brand-name medications from retail pharmacies may be faster if in stock
What Theyre FDA-Approved For Currently, GLP-1 medications are approved for: Type 2 diabetes Obesity and weight management Reducing cardiovascular risk in people with heart or kidney disease MASH (metabolic-associated steatohepatitis) , formerly called NASH, a type of fatty liver disease Microdosing: What It Means Microdosing usually refers to staying at a very low dosesay, 0.25 mg of semaglutidelong-term, rather than gradually increasing to the therapeutic dose